Xpect D Junior Syrup is a pediatric formulation designed to provide symptomatic relief from common cold and allergy-related respiratory conditions. It contains a combination of Phenylephrine (2.5 mg), Chlorpheniramine Maleate (1 mg), and Dextromethorphan Hydrobromide (5 mg) per dose. Phenylephrine acts as a selective alpha-1 adrenergic receptor agonist, effectively reducing nasal congestion by vasoconstriction of the nasal mucosa. Chlorpheniramine Maleate, a first-generation antihistamine, alleviates allergic symptoms such as sneezing, runny nose, and watery eyes by blocking H1 histamine receptors. Dextromethorphan Hydrobromide serves as a centrally acting antitussive, suppressing the cough reflex by acting on the medullary cough center without causing significant sedation. This combination makes Xpect D Junior Syrup suitable for managing symptoms associated with upper respiratory tract infections, allergic rhinitis, and non-productive cough in children. The syrup formulation ensures ease of administration and accurate dosing in pediatric patients. It is recommended to use this medication under medical supervision, adhering to the prescribed dosage to minimize potential side effects such as drowsiness, dry mouth, or gastrointestinal discomfort. Xpect D Junior Syrup should be avoided in children with hypersensitivity to any component, severe hypertension, or concurrent use of monoamine oxidase inhibitors.